| This is a multicenter study wherein the efficacy and safety of standardized 10% β â??glucogallin Saberry (an extract of amla) will be studied against Metformin in newly diagnosed adult male or female patients with Type 2 Diabetes mellitus associated with abnormal amount of lipids in the blood. | A Prospective, randomized, open-label, comparative study to evaluate the efficacy and safety of standardized 10% β â??glucogallin (Saberry), an extract of Emblica officinalis against Metformin 500mg in newly diagnosed patients of type 2 diabetes mellitus associated with dyslipidemia. | CTRI/2019/11/021992 |
